A World First: Automated Local Literature Monitoring for Pharmacovigilance – Download our White Paper Today!
biologit
Database
biologit Database, extensive range of global and local literature sources
At the heart of Biologit’s pharmacovigilance solutions is our state-of-the-art database, built to revolutionise how indexed and non-indexed literature is monitored to identify safety events. Engineered to meet the demands of modern pharmacovigilance, our database integrates real-time intake of huge volumes of scientific and medical literature.
The biologit Database offers unparalleled coverage, including MEDLINE as recommended regulatory authorities, and vast additional scope to ensure rigorous access and compliance for safety screening.
Global Literature Monitoring
The Biologit database is a comprehensive and continuously updated repository of scientific literature, used by organisations around the globe from clinical development to post market. It supports compliant regulatory searches, aggregating all relevant sources via an easy-to use interface.
Extensive global coverage, including MEDLINE
Complies with global regulatory requirements for pharmacovigilance and medical device safety screening
Available on-demand from the biologit Platform
Updated daily
Local Literature Monitoring
Unique and the most extensive source of indexed and non-indexed literature sources of from across the world.
Large open source regional repositories; over 120,000 sources not available on MEDLINE or Embase
World-first managed service product to ingest any local literature source
100% coverage: All required non-indexed sources (websites, print journals) are procured by Biologit
Fully managed: Built-in governance and quality processes, integrated with the Biologit Platform for for seamless regulatory workflows
65+ Million
Entries
40,000
New entries daily
140,000
Journals
170+
Countries
Download our White Paper
Learn more about our world-first product to drive automation in local literature monitoring. Biologit for Local Literature solves the costly and complex problem of how to reliably identify adverse events and relevant safety information across the full spectrum of local literature sources, including non-indexed and hard-to-access country publications.
Key Features
Biologit data includes multilingual drug and device names, synonyms and relevant terms
Integration Machine translation for abstracts and full text, and access to open source full text
Machine Learning and Natural Language Process to accurately find and screen safety information
Multiple source types including indexed and non-indexed journals, websites and print
Access to open source full text articles
Multilingual data from emerging and underrepresented markets to provide a truly global perspective on safety
Advanced search capabilities and programatic access to the data
